World Advanced Therapies Congress & Expo

 

Business Design Centre, London, UK

Pre-conference Workshop Day Monday 30 March

Congress and Exhibition Tuesday 31 March - Wednesday 1 April 2020

 

Research. Develop. Collaborate. Commercialise.

 

2000+
Attendees
500+
Companies
400+
Speakers
200+
Exhibitors
10
Conference Tracks
8
Workshops
80%
Decision Makers

WHAT IS THE ADVANCED THERAPIES CONGRESS?

 

Europe’s most important advanced therapies conference and exhibition with 2000+ attendees and 400+ speakers.


The agenda covers gene therapy, gene edited cell therapies, stem cells & regenerative medicine. The event covers each stage of development of cell, gene and immunotherapy - from bioprocessing through clinical translation to reimbursement, market access and delivery to patient.

 

Watch the Advanced Therapies 2020 Trailer

 

 

 

 

CONFIRMED 2020 SPEAKERS

 

 

 

SEE OUR 2019 SPEAKERS

 

  • Dr Roy Baynes at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Roy Baynes
    Senior Vice President And Head Global Clinical Development, Chief Medical Officer
    Merck Sharp and Dohme (MSD)
    Katherine High at World Advanced Therapies & Regenerative Medicine Congress 2019
    Katherine High
    President And Head, Research And Development
    Spark Therapeutics
    Andrew Obenshain at World Advanced Therapies & Regenerative Medicine Congress 2019
    Andrew Obenshain
    Head Of Europe
    Bluebird Bio
  • Alan Smith at World Advanced Therapies & Regenerative Medicine Congress 2019
    Alan Smith
    Executive Vice President, Technical Operations
    Bellicum Pharmaceuticals
    Shinya Yamanaka at World Advanced Therapies & Regenerative Medicine Congress 2019
    Shinya Yamanaka
    Director And Professor, Center For Ips Cell Research And Application (Cira)
    Kyoto University
    Dr Joanne Kurtzberg at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Joanne Kurtzberg
    Director
    Carolinas Cord Blood Bank At Duke
  • Dr James Miskin at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr James Miskin
    Chief Technical Officer
    Oxford Biomedica
    Frederic Chereau at World Advanced Therapies & Regenerative Medicine Congress 2019
    Frederic Chereau
    Chief Executive Officer
    LogicBio Therapeutics
    Lothar Germeroth at World Advanced Therapies & Regenerative Medicine Congress 2019
    Lothar Germeroth
    Senior Vice President And Managing Director
    Juno Therapeutics GmbH, A Celgene Company
  • Derek Jantz at World Advanced Therapies & Regenerative Medicine Congress 2019
    Derek Jantz
    Co-Founder And Chief Scientific Officer
    Precision Biosciences
    Michael Leek at World Advanced Therapies & Regenerative Medicine Congress 2019
    Michael Leek
    Chief Executive Officer
    TC BioPharm
    Lior Raviv at World Advanced Therapies & Regenerative Medicine Congress 2019
    Lior Raviv
    Vice President Of Development
    Pluristem
  • Edward Rebar at World Advanced Therapies & Regenerative Medicine Congress 2019
    Edward Rebar
    Senior Vice President And Chief Technology Officer
    Sangamo Therapeutics
    Antonio Regalado at World Advanced Therapies & Regenerative Medicine Congress 2019
    Antonio Regalado
    Senior Editor
    M.I.T. Technology Review
    Dominic Schmidt at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dominic Schmidt
    Partner
    Syncona Investment Management Ltd
  • Ra Session II at World Advanced Therapies & Regenerative Medicine Congress 2019
    Ra Session II
    Chief Business Officer
    BridgeBio-Gene Therapy
    Jean-Pierre Latere at World Advanced Therapies & Regenerative Medicine Congress 2019
    Jean-Pierre Latere
    Chief Operating Officer
    Celyad
    Neill Moray Mackenzie at World Advanced Therapies & Regenerative Medicine Congress 2019
    Neill Moray Mackenzie
    Chairman And Board Mamber
    Cellular Therapeutics Ltd
  • Dr Frédéric Triebel at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Frédéric Triebel
    Chief Scientific Officer And Medical Officer
    Immutep Ltd
    Jacqueline Barry at World Advanced Therapies & Regenerative Medicine Congress 2019
    Jacqueline Barry
    Chief Clinical Officer
    Cell and Gene Therapy Catapult
    Jaap Boelens at World Advanced Therapies & Regenerative Medicine Congress 2019
    Jaap Boelens
    Chief; Stem Cell Transplantation And Cellular Therapies Pediatrics
    Memorial Sloan-Kettering Cancer Center
  • Armando Cuesta Díaz at World Advanced Therapies & Regenerative Medicine Congress 2019
    Armando Cuesta Díaz
    Partner
    Ilana Capital
    Daniel Gibson at World Advanced Therapies & Regenerative Medicine Congress 2019
    Daniel Gibson
    Head Of Innovation And Commercialation
    Anthony Nolan
    Adam Gridley at World Advanced Therapies & Regenerative Medicine Congress 2019
    Adam Gridley
    President And Chief Executive Officer
    Histogenics Corporation
  • Alan Muir at World Advanced Therapies & Regenerative Medicine Congress 2019
    Alan Muir
    Director And Co-Founder
    Seven Hills Venture Partners
    David Pauza at World Advanced Therapies & Regenerative Medicine Congress 2019
    David Pauza
    Chief Science Officer
    American Gene Technologies International Inc.
    Beth Shaz at World Advanced Therapies & Regenerative Medicine Congress 2019
    Beth Shaz
    Chief Medical Officer
    New York Blood Center
  • Jonathan Sheffield at World Advanced Therapies & Regenerative Medicine Congress 2019
    Jonathan Sheffield
    Chief Executive Officer
    NIHR Clinical Research Network
    Dr Andrea Spezzi at World Advanced Therapies & Regenerative Medicine Congress 2019
    Dr Andrea Spezzi
    Chief Medical Officer And Co-Founder
    Orchard Therapeutics
    Marcos Valadares at World Advanced Therapies & Regenerative Medicine Congress 2019
    Marcos Valadares
    Co-Founder
    Pluricell
  • Rogerio Vivaldi at World Advanced Therapies & Regenerative Medicine Congress 2019
    Rogerio Vivaldi
    Chief Executive Officer
    Sigilon Therapeutics
    Miguel Forte at World Advanced Therapies & Regenerative Medicine Congress 2019
    Miguel Forte
    Chief Executive Officer
    Zelluna Immunotherapy
    Edward Hodgkin at World Advanced Therapies & Regenerative Medicine Congress 2019
    Edward Hodgkin
    Partner
    Syncona Partners
  • Hans Keirstead at World Advanced Therapies & Regenerative Medicine Congress 2019
    Hans Keirstead
    Chief Executive Officer
    AiVita Biomedical
    Douglas Losordo at World Advanced Therapies & Regenerative Medicine Congress 2019
    Douglas Losordo
    Chief Medical Officer
    Caladrius Biosciences
    David Mazzo at World Advanced Therapies & Regenerative Medicine Congress 2019
    David Mazzo
    Chief Executive Officer
    Caladrius Biosciences
  • David Morrow at World Advanced Therapies & Regenerative Medicine Congress 2019
    David Morrow
    Program Manager
    EATRIS
    Mike Rice at World Advanced Therapies & Regenerative Medicine Congress 2019
    Mike Rice
    Principal
    Cello Health BioConsulting Previously Defined Health
    Mark Sawicki at World Advanced Therapies & Regenerative Medicine Congress 2019
    Mark Sawicki
    Chief Commercial Officer
    Cryoport Inc
  • Claudia Mitchell at World Advanced Therapies & Regenerative Medicine Congress 2019
    Claudia Mitchell
    Claudia Mitchell, SVP, Product and Portfolio Strategy
    Astellas Pharma
    Stephan Grupp at World Advanced Therapies & Regenerative Medicine Congress 2019
    Stephan Grupp
    Chief, Cellular Therapy And Transplant Section
    The Children's Hospital of Philadelphia
    Sam Hall at World Advanced Therapies & Regenerative Medicine Congress 2019
    Sam Hall
    Partner
    Apple Tree Partners
  • Takashi Kei Kishimoto at World Advanced Therapies & Regenerative Medicine Congress 2019
    Takashi Kei Kishimoto
    Chief Science Officer
    Selecta Biosciences Inc
    Ross Macdonald at World Advanced Therapies & Regenerative Medicine Congress 2019
    Ross Macdonald
    Chief Executive Officer
    Cynata Therapeutics Ltd
    Stefanos Theoharis at World Advanced Therapies & Regenerative Medicine Congress 2019
    Stefanos Theoharis
    Senior Vice President Of Corporate Development And Partnering
    Cell Medica Ltd

 

 

HUNDREDS OF WORLD LEADING ATTENDEES in 2019 INCLUDED

 

Novartis

AstraZeneca

AveXis

Avrobio

Bellicum

bluebird bio

bluerock

Cellectis

celyad

chiesi

genethon

Gilead

GSK

Histogenics

Juno Therapeutics, a Celgene Company

LogicBio 

MSKCC

Merck Research Laboaratories

mesoblast

Nightstar Therapeutics

NHS

Orchard Therapeutics

Oxford BioMedica

Pfizer

Precision Biosciences

Sangamo Therapeutics

sanofi

Selecta Biosciences

Semma Therapeutics

Sentien Biotechnology

Sigilon Tehraptueics

Spark Therapeutics

TC Biopharm

Telethon

Zelluna Immunotherapy


 

2019 SUPPORTING PARTNERS

 

 

 

2019 SPONSORS & EXHIBITORS

 

  • Platinum Sponsor

    Associate

    Silver Sponsor

  • Associate

    Gold Sponsor

    Gold Sponsor

  • Silver Sponsor

    Silver Sponsor

    Silver Sponsor

  • Silver Sponsor

    Silver Sponsor

    Silver Sponsor

  • Silver Sponsor

    Silver Sponsor

    Associate Sponsor

  • Associate Sponsor

    Associate Sponsor

    Associate Sponsor

  • Associate Sponsor

    Associate Sponsor

    Associate Sponsor

  • Associate Sponsor

    Associate Sponsor

    Associate Sponsor

  • Associate Sponsor

    Associate Sponsor

    Supporter

  • Supporter

    Supporter

    Supporter

  • Associate Sponsor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Supporter

    Supporter

    Supporter

  • Supporter

    Supporter

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

    Exhibitor

  • Exhibitor

    Exhibitor

 

 

 

SPONSORSHIP OPPORTUNITIES

 

 

Mark Your Calendar
Monday 30 March - Wednesday 1 April 2020

 

 

REGISTER NOW

 

 

Sign Up for Event Updates

“The organization was perfect, and the topics were very interesting. I will be pleased to participate next year. Congratulations for this congress.”

 

Didier Caizergues, Head of Regulatory Affairs Department, Genethon

 

 

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.